These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11980656)
1. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Dorsey R; Kundu N; Yang Q; Tannenbaum CS; Sun H; Hamilton TA; Fulton AM Cancer Res; 2002 May; 62(9):2606-10. PubMed ID: 11980656 [TBL] [Abstract][Full Text] [Related]
2. Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors. Sun H; Kundu N; Dorsey R; Jackson MJ; Fulton AM J Immunother; 2001; 24(2):138-43. PubMed ID: 11265771 [TBL] [Abstract][Full Text] [Related]
3. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. Tannenbaum CS; Tubbs R; Armstrong D; Finke JH; Bukowski RM; Hamilton TA J Immunol; 1998 Jul; 161(2):927-32. PubMed ID: 9670971 [TBL] [Abstract][Full Text] [Related]
4. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma. Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236 [TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma. Bukowski RM; Rayman P; Molto L; Tannenbaum CS; Olencki T; Peereboom D; Tubbs R; McLain D; Budd GT; Griffin T; Novick A; Hamilton TA; Finke J Clin Cancer Res; 1999 Oct; 5(10):2780-9. PubMed ID: 10537342 [TBL] [Abstract][Full Text] [Related]
7. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts. Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726 [TBL] [Abstract][Full Text] [Related]
8. A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen. Molesworth-Kenyon SJ; Oakes JE; Lausch RN J Leukoc Biol; 2005 Apr; 77(4):552-9. PubMed ID: 15629884 [TBL] [Abstract][Full Text] [Related]
9. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity. Yang X; Chu Y; Wang Y; Zhang R; Xiong S J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511 [TBL] [Abstract][Full Text] [Related]
10. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933 [TBL] [Abstract][Full Text] [Related]
11. Expression of the Chemokines IP-10 and Mig in IL-10 Transduced Tumors. Sun H; Kundu N; Dorsey R; Jackson MJ; Fulton AM J Immunother (1991); 2001 Mar; 24(2):138-143. PubMed ID: 11449070 [TBL] [Abstract][Full Text] [Related]
12. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model. Walser TC; Ma X; Kundu N; Dorsey R; Goloubeva O; Fulton AM J Immunother; 2007; 30(5):490-8. PubMed ID: 17589289 [TBL] [Abstract][Full Text] [Related]
13. Expression of the Mig (CXCL9) gene in murine lung carcinoma cells generated angiogenesis-independent antitumor effects. Wang YQ; Wada A; Ugai S; Tagawa M Oncol Rep; 2003; 10(4):909-13. PubMed ID: 12792744 [TBL] [Abstract][Full Text] [Related]
14. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. Tannenbaum CS; Wicker N; Armstrong D; Tubbs R; Finke J; Bukowski RM; Hamilton TA J Immunol; 1996 Jan; 156(2):693-9. PubMed ID: 8543822 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685 [TBL] [Abstract][Full Text] [Related]
16. Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors. Liu Y; Huang H; Saxena A; Xiang J Cancer Gene Ther; 2002 Jun; 9(6):533-42. PubMed ID: 12032664 [TBL] [Abstract][Full Text] [Related]
17. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of the MIG and IP-10 genes transferred with poly [D,L-2,4-diaminobutyric acid] on murine neuroblastoma. Tominaga M; Iwashita Y; Ohta M; Shibata K; Ishio T; Ohmori N; Goto T; Sato S; Kitano S Cancer Gene Ther; 2007 Aug; 14(8):696-705. PubMed ID: 17514193 [TBL] [Abstract][Full Text] [Related]
19. Intramuscular electroporation delivery of IFN-alpha gene therapy for inhibition of tumor growth located at a distant site. Li S; Zhang X; Xia X; Zhou L; Breau R; Suen J; Hanna E Gene Ther; 2001 Mar; 8(5):400-7. PubMed ID: 11313817 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15. Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]